ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arkansas » Rheumatology

Top Rheumatology Prescribers in Arkansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
COLUMBUS BROWN M.D.

Rheumatology

10,263

$989K

805
225 are 65+

41%
patients receiving schedule two controlled substances

Avg: 4%

42%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 22%

$96
Average prescription price

Avg: $114

RANDY ROBERTS MD

Rheumatology

9,331

$958K

630
450 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 12%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$103
Average prescription price

Avg: $114

THOMAS DYKMAN MD

Rheumatology

8,632

$752K

481
334 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

25%
patients receiving schedule three controlled substances

Avg: 12%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 22%

$87
Average prescription price

Avg: $114

LESLIE MCCASLAND M.D.

Rheumatology

7,972

$1.2M

502
292 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 22%

$150
Average prescription price

Avg: $114

TAMER ALSEBAI M.D.

Rheumatology

7,835

$1.03M

528
321 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$131
Average prescription price

Avg: $114

JASEN CHI M.D.

Rheumatology

7,312

$1M

715
471 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

29%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 22%

$137
Average prescription price

Avg: $114

JAMES LOGAN MD

Rheumatology

6,957

$970K

609
362 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$139
Average prescription price

Avg: $114

PRESTON BANDY M.D.

Rheumatology

6,597

$522K

460
332 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 12%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$79
Average prescription price

Avg: $114

JAMES DENEKE MD

Rheumatology

6,551

$1.32M

555
357 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$202
Average prescription price

Avg: $114

WALTON TOY MD

Rheumatology

6,546

$1.01M

440
288 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$154
Average prescription price

Avg: $114

THOMAS KOVALESKI M.D.

Rheumatology

6,476

$445K

394
313 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 22%

$69
Average prescription price

Avg: $114

MELODY ST. JOHN MD

Rheumatology

6,214

$556K

618
411 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 22%

$90
Average prescription price

Avg: $114

ELEANOR LIPSMEYER M.D.

Rheumatology

6,111

$398K

314
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 12%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $114

BEATA FILIP-MAJEWSKI M.D.

Rheumatology

6,100

$1.12M

475
291 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 22%

$184
Average prescription price

Avg: $114

RONALD ANGELO RUBIO M.D.

Rheumatology

5,438

$897K

464
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$165
Average prescription price

Avg: $114

ROBERT BREWER M.D.

Rheumatology

5,296

$239K

269
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $114

RICHARD HOUK M.D.

Rheumatology

4,907

$173K

274
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 12%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 22%

$35
Average prescription price

Avg: $114

DONALD LEONARD MD

Rheumatology

4,823

$453K

175
62 are 65+

51%
patients receiving schedule two controlled substances

Avg: 4%

75%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 22%

$94
Average prescription price

Avg: $114

RUSSELL BRANUM MD

Rheumatology

4,737

$559K

376
227 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 22%

$118
Average prescription price

Avg: $114

SAFWAN SAKR MD

Rheumatology

4,285

$1.13M

442
253 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 22%

$263
Average prescription price

Avg: $114

LAURA TRIGG M.D.

Rheumatology

3,891

$261K

292
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 12%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $114

JAMES ABRAHAM M.D.

Rheumatology

3,783

$286K

308
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 22%

$76
Average prescription price

Avg: $114

SHERMAN JONES M.D.

Rheumatology

2,370

$164K

242
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 12%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$69
Average prescription price

Avg: $114

LISA LOWERY M.D.

Rheumatology

2,223

$345K

181
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$155
Average prescription price

Avg: $114

JESSICA SHORT MD

Rheumatology

2,037

$176K

225
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$86
Average prescription price

Avg: $114

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank